Bendamustine Monohydroxy Impurity
| Product Name | Bendamustine Monohydroxy Impurity |
|---|---|
| Alternate Names | Bendamustine Impurities, Impurities of Bendamustine |
| CAT No. | CS-O-07343 |
| CAS No. | 109882-27-1 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 339.82 g/mol |
| Mol. For. | C₁₆H₂₂ClN₃O₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Bendamustine |
| Purity | >98% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | CN1C2=C(C=C(C=C2)N(CCO)CCCl)N=C1CCCC(=O)O |
| Canonical Smiles | CN1C2=C(C=C(C=C2)N(CCO)CCCl)N=C1CCCC(=O)O |
| InchIKey | PFTRYOMJJKBZKV-UHFFFAOYSA-N |
| Inchl | InChI=1S/C16H22ClN3O3/c1-19-14-6-5-12(20(8-7-17)9-10-21)11-13(14)18-15(19)3-2-4-16(22)23/h5-6,11,21H,2-4,7-10H2,1H3,(H,22,23) |
| IUPAC | 4-[5-[2-chloroethyl(2-hydroxyethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Bendamustine Monohydroxy Impurity is a chemical compound that is used in the pharmaceutical industry to help identify and measure impurities in Bendamustine, a medication that is used to treat certain types of cancer. This impurity is also known as 1-(4-amino-2-methylpyrimidin-5-yl)butan-1-ol and is a metabolite of Bendamustine.
In terms of its chemical information, Bendamustine Monohydroxy Impurity has a molecular weight of 176.22 g/mol and a molecular formula of C9H14N2O. It is a white to off-white solid that is soluble in water and has a melting point of 100-102°C.
The usage of Bendamustine Monohydroxy Impurity is primarily in the development and manufacturing of Bendamustine. It is used as a reference standard to ensure the purity and quality of Bendamustine, which is important for ensuring its safety and effectiveness in treating cancer. Additionally, Bendamustine Monohydroxy Impurity is used in research studies to investigate the pharmacokinetics and metabolism of Bendamustine.
Overall, Bendamustine Monohydroxy Impurity is a crucial component in the pharmaceutical industry for ensuring the quality and efficacy of Bendamustine, a medication that is used to treat cancer patients.
Get an Instant Quote
Related Compounds
Bendamustine Related Compound B | Bendamustine Isopropyl Ester Impurity | Bendamustine Nitro Ethyl Ester Impurity | Bendamustine Related Impurity 17 | Bendamustine Monohydroxy Isopropyl Ester Impurity | Bendamustine Related Impurity 4 | Bendamustine Methyl Ester | Bendamustine Ether Impurity | Bendamustine Impurity 14 HCl salt | Deschloroethyl bendamustine | N-Nitroso Bendamustine Impurity | Bendamustine Ethyl Ester | Bendamustine Related Compound G | Bendamustine Methyl Ester (HCl) | Bendamustine Related Impurity 3 | Bendamustine Related Compound D(Secondary Standards traceble to USP) | Bendamustine Impurity D | Bendamustine Impurity HCl salt | Bendamustine Deschloroethyl Acid Ethyl Ester | Bendamustine Impurity 10 HCl salt | Bendamustine USP Related Compound A | Dideschloroethyl Bendamustine | Bendamustine Propylene Glycol Ester 1 | Bendamustine PEG ester mixture | Deschloroethyl Bendamustine ethynylamide impurity | Dihydroxy Bendamustine | Bendamustine Monohydroxy Acid Impurity | Bendamustine Trihydroxy Dimer Impurity | Bendamustine N-Alkylated Impurity Hydrochloride | Bendamustine Deschloroethyl Acid Impurity | Bendamustine Dideschloroethyl Ethyl Ester | Bendamustine USP Related Compound I (HCl) | Bendamustine D-Mannitol Ester | Bendamustine Impurity C | Bendamustine Impurity B | Bendamustine Impurity 1 | Bendamustine Chloro Dimer Impurity | Bendamustine Ethyl Impurity | Bendamustine Isopropyl Ester HCl |